Liquidia (LQDA) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

LQDA Stock Forecast

Liquidia stock forecast is as follows: an average price target of $17.17 (represents a 69.16% upside from LQDA’s last price of $10.15) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

LQDA Price Target

The average price target for Liquidia (LQDA) is $17.17 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $27.00 to $3.00. This represents a potential 69.16% upside from LQDA's last price of $10.15.

LQDA Analyst Ratings

Buy

According to 6 Wall Street analysts, Liquidia's rating consensus is 'Buy'. The analyst rating breakdown for LQDA stock is 0 'Strong Buy' (0.00%), 6 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Liquidia Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 20, 2024	Jason Gerberry	Bank of America Securities	-	-	134.93%	126.60%
Aug 19, 2024	Kambiz Yazdi	Jefferies	-	-	77.27%	67.49%
Aug 19, 2024	Strong Buy	Raymond James	-	-	174.95%	166.01%
May 14, 2024	Kambiz Yazdi	Jefferies	-	-	92.31%	126.60%
Sep 02, 2022		Needham	-	-	229.22%	57.64%
Sep 01, 2022	Liana Moussatos	Wedbush	-	-	-48.01%	-70.44%
Jul 20, 2022		BTIG	-	-	213.65%	67.49%

Row per page

Go to

The latest Liquidia stock forecast, released on Aug 20, 2024 by Jason Gerberry from Bank of America Securities, set a price target of $23.00, which represents a 134.93% increase from the stock price at the time of the forecast ($9.79), and a 126.60% increase from LQDA last price ($10.15).

Liquidia Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	4
Avg Price Target	-	-	$22.50
Last Closing Price	$10.15	$10.15	$10.15
Upside/Downside	-100.00%	-100.00%	121.67%

In the current month, the average price target of Liquidia stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Liquidia's last price of $10.15. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 03, 2024	Raymond James	Buy	Buy	Hold
Aug 20, 2024	BTIG	Buy	Buy	Hold
Aug 20, 2024	H.C. Wainwright	Buy	Buy	Hold
Aug 19, 2024	Jefferies	Buy	Buy	Hold
Aug 19, 2024	Raymond James	Outperform	Strong Buy	Upgrade
Aug 16, 2024	Raymond James		Outperform	Initialise
Aug 08, 2024	Needham	Buy	Buy	Hold
Jul 18, 2024	Needham	Buy	Buy	Hold
Jun 25, 2024	Needham	Buy	Buy	Hold
Jun 24, 2024	Oppenheimer		Perform	Initialise

Row per page

Go to

Liquidia's last stock rating was published by Raymond James on Oct 03, 2024. The company gave LQDA a "Buy" rating, the same as its previous rate.

Liquidia Financial Forecast

Liquidia Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Sep 19	Jun 19	Mar 19	Sep 18
Revenue	-	-	-	-	-	-	-	-	$4.53M	$3.68M	$4.79M	$4.49M	$5.36M	$3.17M	$3.92M	$3.49M	$-3.34M	$3.18M	$3.38M	$3.08M	-	$8.07M	-	$169.73K
Avg Forecast	$28.54M	$15.98M	$6.48M	$4.17M	$4.54M	$4.16M	$9.45M	$4.47M	$4.73M	$4.33M	$4.32M	$3.95M	$3.55M	$3.76M	$3.59M	$3.30M	$3.05M	$2.73M	$2.04M	$951.25K	$644.50K	$683.00K	$925.50K	$116.56K
High Forecast	$36.01M	$20.17M	$8.17M	$5.26M	$6.06M	$5.25M	$9.45M	$4.47M	$5.61M	$4.33M	$5.45M	$4.98M	$4.48M	$3.76M	$3.59M	$3.30M	$3.05M	$2.73M	$2.04M	$951.25K	$644.50K	$683.00K	$925.50K	$139.87K
Low Forecast	$22.73M	$12.73M	$5.16M	$3.32M	$3.39M	$3.31M	$9.45M	$4.47M	$3.76M	$4.33M	$3.44M	$3.14M	$2.83M	$3.76M	$3.59M	$3.30M	$3.05M	$2.73M	$2.04M	$951.25K	$644.50K	$683.00K	$925.50K	$93.25K
# Analysts	1	1	1	2	6	3	4	4	5	4	4	4	3	3	3	3	4	4	4	7	13	13	13	15
Surprise %	-	-	-	-	-	-	-	-	0.96%	0.85%	1.11%	1.14%	1.51%	0.84%	1.09%	1.06%	-1.10%	1.16%	1.65%	3.24%	-	11.82%	-	1.46%

Liquidia's average Quarter revenue forecast for Mar 24 based on 4 analysts is $4.47M, with a low forecast of $4.47M, and a high forecast of $4.47M. LQDA's average Quarter revenue forecast represents a -1.25% decrease compared to the company's last Quarter revenue of $4.53M (Dec 23).

Liquidia EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Sep 19	Jun 19	Mar 19	Sep 18
# Analysts	1	1	1	2	6	3	4	4	5	4	4	4	3	3	3	3	4	4	4	7	13	13	13	15
EBITDA	-	-	-	-	-	-	-	-	$-25.86M	$-14.89M	$-22.82M	$-8.31M	$-5.83M	$-7.34M	$-7.90M	$-13.52M	$-11.36M	$-5.53M	$-4.76M	$-7.37M	$-12.34M	$-5.03M	$-12.94M	$-8.63M
Avg Forecast	$-28.54M	$-15.98M	$-6.48M	$-4.17M	$-4.54M	$-4.16M	$-9.45M	$-6.98M	$-4.73M	$-4.33M	$-4.32M	$-7.47M	$-9.43M	$-3.76M	$-3.59M	$-7.98M	$-3.05M	$-2.73M	$-2.04M	$-7.37M	$-644.50K	$-683.00K	$-8.58M	$-5.16M
High Forecast	$-22.73M	$-12.73M	$-5.16M	$-3.32M	$-3.39M	$-3.31M	$-9.45M	$-5.58M	$-3.76M	$-4.33M	$-3.44M	$-5.97M	$-7.54M	$-3.76M	$-3.59M	$-6.39M	$-3.05M	$-2.73M	$-2.04M	$-5.90M	$-644.50K	$-683.00K	$-6.87M	$-4.13M
Low Forecast	$-36.01M	$-20.17M	$-8.17M	$-5.26M	$-6.06M	$-5.25M	$-9.45M	$-8.38M	$-5.61M	$-4.33M	$-5.45M	$-8.96M	$-11.31M	$-3.76M	$-3.59M	$-9.58M	$-3.05M	$-2.73M	$-2.04M	$-8.85M	$-644.50K	$-683.00K	$-10.30M	$-6.19M
Surprise %	-	-	-	-	-	-	-	-	5.46%	3.44%	5.29%	1.11%	0.62%	1.95%	2.20%	1.69%	3.73%	2.02%	2.33%	1.00%	19.14%	7.36%	1.51%	1.67%

undefined analysts predict LQDA's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Liquidia's previous annual EBITDA (undefined) of $NaN.

Liquidia Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Sep 19	Jun 19	Mar 19	Sep 18
# Analysts	1	1	1	2	6	3	4	4	5	4	4	4	3	3	3	3	4	4	4	7	13	13	13	15
Net Income	-	-	-	-	-	-	-	-	$-27.45M	-	-	$-13.13M	$-5.97M	$-9.35M	$-9.92M	$-16.94M	-	$-7.28M	$-6.55M	$-9.18M	$-13.42M	$-5.90M	$-13.77M	$-9.67M
Avg Forecast	$-31.99M	$-38.94M	$-31.58M	$-28.81M	$-29.93M	$-29.27M	$-26.75M	$-7.67M	$-18.54M	$-16.85M	$-12.72M	$-8.20M	$-10.09M	$-13.41M	$-18.15M	$-8.77M	$-9.36M	$-9.17M	$-12.04M	$-9.18M	$-45.61M	$-48.92M	$-9.04M	$-5.79M
High Forecast	$-23.53M	$-28.65M	$-23.23M	$-21.19M	$-19.95M	$-21.53M	$-19.67M	$-6.13M	$-17.73M	$-12.39M	$-9.36M	$-6.56M	$-8.07M	$-13.41M	$-18.15M	$-7.01M	$-9.36M	$-9.17M	$-12.04M	$-7.35M	$-45.61M	$-48.92M	$-7.23M	$-4.63M
Low Forecast	$-42.88M	$-52.20M	$-42.33M	$-38.62M	$-37.60M	$-39.23M	$-35.85M	$-9.20M	$-19.34M	$-22.58M	$-17.05M	$-9.84M	$-12.11M	$-13.41M	$-18.15M	$-10.52M	$-9.36M	$-9.17M	$-12.04M	$-11.02M	$-45.61M	$-48.92M	$-10.84M	$-6.94M
Surprise %	-	-	-	-	-	-	-	-	1.48%	-	-	1.60%	0.59%	0.70%	0.55%	1.93%	-	0.79%	0.54%	1.00%	0.29%	0.12%	1.52%	1.67%

Liquidia's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. LQDA's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Liquidia SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Sep 19	Jun 19	Mar 19	Sep 18
# Analysts	1	1	1	2	6	3	4	4	5	4	4	4	3	3	3	3	4	4	4	7	13	13	13	15
SG&A	-	-	-	-	-	-	-	-	$17.14M	$10.56M	$9.24M	$7.79M	$6.19M	$6.74M	$6.94M	$12.54M	$8.47M	$4.88M	$4.42M	$5.34M	$2.38M	$2.41M	$3.02M	$2.28M
Avg Forecast	$257.29M	$144.08M	$58.41M	$37.57M	$40.95M	$37.48M	$85.19M	$40.34M	$42.66M	$39.07M	$38.90M	$35.59M	$2.43M	$33.90M	$32.35M	$29.71M	$27.46M	$24.65M	$18.43M	$8.58M	$5.81M	$6.16M	$8.34M	$1.05M
High Forecast	$324.66M	$181.81M	$73.70M	$47.40M	$54.61M	$47.30M	$85.19M	$40.34M	$50.56M	$39.07M	$49.09M	$44.91M	$2.91M	$33.90M	$32.35M	$29.71M	$27.46M	$24.65M	$18.43M	$8.58M	$5.81M	$6.16M	$8.34M	$1.26M
Low Forecast	$204.96M	$114.77M	$46.53M	$29.93M	$30.58M	$29.86M	$85.19M	$40.34M	$33.87M	$39.07M	$30.99M	$28.35M	$1.94M	$33.90M	$32.35M	$29.71M	$27.46M	$24.65M	$18.43M	$8.58M	$5.81M	$6.16M	$8.34M	$840.69K
Surprise %	-	-	-	-	-	-	-	-	0.40%	0.27%	0.24%	0.22%	2.55%	0.20%	0.21%	0.42%	0.31%	0.20%	0.24%	0.62%	0.41%	0.39%	0.36%	2.17%

Liquidia's average Quarter SG&A projection for Mar 24 is $40.34M, based on 4 Wall Street analysts, with a range of $40.34M to $40.34M. The forecast indicates a 135.29% rise compared to LQDA last annual SG&A of $17.14M (Dec 23).

Liquidia EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Sep 19	Jun 19	Mar 19	Sep 18
# Analysts	1	1	1	2	6	3	4	4	5	4	4	4	3	3	3	3	4	4	4	7	13	13	13	15
EPS	-	-	-	-	-	-	-	-	$-0.42	-	-	$-0.20	$-0.10	$-0.15	$-0.16	$-0.32	-	$-0.14	$-0.13	$-0.21	$-0.72	$-0.31	$-0.86	$-0.83
Avg Forecast	$-0.41	$-0.50	$-0.40	$-0.37	$-0.38	$-0.37	$-0.34	$-0.32	$-0.24	$-0.22	$-0.16	$-0.16	$-0.16	$-0.18	$-0.24	$-0.21	$-0.12	$-0.12	$-0.16	$-0.21	$-0.60	$-0.64	$-0.63	$-0.34
High Forecast	$-0.30	$-0.37	$-0.30	$-0.27	$-0.25	$-0.27	$-0.25	$-0.24	$-0.23	$-0.16	$-0.12	$-0.12	$-0.11	$-0.18	$-0.24	$-0.21	$-0.12	$-0.12	$-0.16	$-0.21	$-0.60	$-0.64	$-0.63	$-0.27
Low Forecast	$-0.55	$-0.67	$-0.54	$-0.49	$-0.48	$-0.50	$-0.46	$-0.43	$-0.25	$-0.29	$-0.22	$-0.22	$-0.21	$-0.18	$-0.24	$-0.21	$-0.12	$-0.12	$-0.16	$-0.21	$-0.60	$-0.64	$-0.63	$-0.41
Surprise %	-	-	-	-	-	-	-	-	1.77%	-	-	1.23%	0.63%	0.86%	0.67%	1.54%	-	1.17%	0.83%	0.99%	1.21%	0.48%	1.36%	2.44%

According to undefined Wall Street analysts, Liquidia's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to LQDA previous annual EPS of $NaN (undefined).

Liquidia Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
XFOR	X4 Pharmaceuticals	-	-	891.89%	Buy
GOSS	Gossamer Bio	-	-	468.18%	Buy
INZY	Inozyme Pharma	-	-	445.35%	Buy
LRMR	Larimar Therapeutics	-	-	231.65%	Buy
ABOS	Acumen Pharmaceuticals	-	-	203.03%	Buy
AGEN	Agenus	-	-	179.72%	Hold
LYRA	Lyra Therapeutics	-	-	177.78%	Hold
TERN	Terns Pharmaceuticals	-	-	149.56%	Buy
KALV	KalVista Pharmaceuticals	-	-	142.98%	Buy
IMCR	Immunocore	-	-	120.27%	Buy
REPL	Replimune Group	-	-	119.00%	Buy
LEGN	Legend Biotech	-	-	108.03%	Buy
KRON	Kronos Bio	-	-	87.36%	Buy
LQDA	Liquidia	-	-	69.16%	Buy
NRXP	NRx Pharmaceuticals	-	-	62.60%	Buy
BMRN	BioMarin Pharmaceutical	-	-	60.28%	Buy
GERN	Geron	-	-	52.49%	Buy
PCVX	Vaxcyte	-	-	40.29%	Buy
MIRM	Mirum Pharmaceuticals	-	-	31.67%	Buy
TECH	Bio-Techne	-	-	29.05%	Buy
AMLX	Amylyx Pharmaceuticals	-	-	28.52%	Buy
UTHR	United Therapeutics	-	-	-2.49%	Buy

LQDA Forecast FAQ

Is Liquidia a good buy?

Yes, according to 6 Wall Street analysts, Liquidia (LQDA) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 100.00% of LQDA's total ratings.

What is LQDA's price target?

Liquidia (LQDA) average price target is $17.17 with a range of $3 to $27, implying a 69.16% from its last price of $10.15. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Liquidia stock go up soon?

According to Wall Street analysts' prediction for LQDA stock, the company can go up by 69.16% (from the last price of $10.15 to the average price target of $17.17), up by 166.01% based on the highest stock price target, and down by -70.44% based on the lowest stock price target.

Can Liquidia stock reach $20?

LQDA's highest twelve months analyst stock price target of $27 supports the claim that Liquidia can reach $20 in the near future.

What are Liquidia's analysts' financial forecasts?

Liquidia's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $22.62M (high $25.23M, low $20.63M), average EBITDA is $-25.13M (high $-21.737M, low $-29.129M), average net income is $-93.604M (high $-67.286M, low $-122M), average SG&A $203.96M (high $227.43M, low $185.96M), and average EPS is $-1.421 (high $-1.019, low $-1.872). LQDA's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $55.16M (high $69.61M, low $43.94M), average EBITDA is $-55.164M (high $-43.945M, low $-69.609M), average net income is $-131M (high $-96.603M, low $-176M), average SG&A $497.33M (high $627.57M, low $396.19M), and average EPS is $-1.677 (high $-1.233, low $-2.248).

Did the LQDA's actual financial results beat the analysts' financial forecasts?

Based on Liquidia's last annual report (Dec 2023), the company's revenue was $17.49M, beating the average analysts forecast of $17.33M by 0.92%. Apple's EBITDA was $-73.384M, beating the average prediction of $-20.846M by 252.03%. The company's net income was $0, missing the average estimation of $-56.302M by -100.00%. Apple's SG&A was $44.74M, missing the average forecast of $156.22M by -71.36%. Lastly, the company's EPS was $0, missing the average prediction of $-0.777 by -100.00%. In terms of the last quarterly report (Dec 2023), Liquidia's revenue was $4.53M, missing the average analysts' forecast of $4.73M by -4.24%. The company's EBITDA was $-25.858M, beating the average prediction of $-4.732M by 446.50%. Liquidia's net income was $-27.45M, beating the average estimation of $-18.538M by 48.08%. The company's SG&A was $17.14M, missing the average forecast of $42.66M by -59.81%. Lastly, the company's EPS was $-0.42, beating the average prediction of $-0.237 by 77.44%